Atlas Trials

Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of OPT-302 With or Without Lucentis™ in Patients With Wet AMD

Clinical trial NCT02543229 · COMPLETED

Trial details

NCT number
NCT02543229
Sponsor
Opthea Limited
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Eye DiseasesMacular DegenerationRetinal DiseasesRetinal DegenerationNeovascularization, Pathologic
Start date
2015-07-01
Primary completion
2017-02-07
Enrollment
51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.